Top stories

LegalHigh Court upholds corporate visa refusal: Implications for businesses
Dee-dee Mathelela 21 hours





LifestyleSA’s best-dressed office competition launches with R100K in corporate clothing up for grabs
Imagemakers 11 Aug 2025
More news





















Sanofi-Aventis has told the U.S. Food and Drug Administration its rimonobant antiobesity drug, also sold under the Acomplia brand, brings a higher risk of suicidal thoughts than placebo, and it does not recommend the treatment for patients suffering from major depression.